Autolus Therapeutics Plc ADR (AUTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 269 | 404 | 680 | 293 | 338 |
| Gross Profit | 269 | 404 | 680 | 293 | 338 |
| Operating Expenses | 40,141 | 47,734 | 43,388 | 39,837 | 38,901 |
| Operating Income | -39,872 | -47,330 | -42,708 | -39,544 | -38,563 |
| Other Income | 882 | -1,112 | -2,472 | 478 | 4,994 |
| Pre-tax Income | -38,990 | -48,442 | -45,180 | -39,066 | -33,569 |
| Income Tax | -5,724 | -5,581 | -7,865 | -7,021 | -3,696 |
| Net Income Continuous | -33,266 | -42,861 | -37,315 | -32,045 | -29,873 |
| Net Income | $-33,266 | $-42,861 | $-37,315 | $-32,045 | $-29,873 |
| EPS Basic Total Ops | -0.53 | -0.82 | -0.72 | -0.62 | -0.60 |
| EPS Basic Continuous Ops | -0.53 | -0.82 | -0.72 | -0.62 | -0.60 |
| EPS Diluted Total Ops | -0.53 | -0.82 | -0.72 | -0.62 | -0.60 |
| EPS Diluted Continuous Ops | -0.53 | -0.82 | -0.72 | -0.62 | -0.60 |
| EBITDA(a) | $-38,210 | $-45,668 | $-41,240 | $-38,277 | $-37,302 |